Exceptional Response to AKT Inhibition in Patients With Breast Cancer and Germline PTEN Mutations.
View/ Open
Date
2019-01-01Author
Kingston, B
Bailleux, C
Delaloge, S
Schiavon, G
Scott, V
Lacroix-Triki, M
Carr, TH
Kozarewa, I
Gevensleben, H
Kemp, Z
Pearson, A
Turner, N
André, F
Type
Journal Article
Metadata
Show full item recordCollections
Research team
Molecular Oncology
Language
eng
Date accepted
2019-10-03
License start date
2019-01
Citation
JCO precision oncology, 2019, 3
Publisher
American Society of Clinical Oncology (ASCO)